In addition, activation of the ERK, JNK or p38 MAPK pathways using agonists efficiently reversed the inhibitory effect of overexpressing GPR84 on osteoclast formation in the tumor microenvironment (Fig. 3C, D). The gene discussed is MAPK8; the disease is neoplasm.